This inventor holds 7 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Sequenom, Inc., Agena Bioscience, Inc., Juno Diagnostics, Inc.. Active years: 2011-2022.
Company Filing History:
5 out of 190 
1 out of 25 
1 out of 1 Years Active: 2011-2022
Title: Paul Andrew Oeth: Innovator in Liquid Biopsy Technologies
Introduction
Paul Andrew Oeth is a prominent inventor based in San Diego, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of liquid biopsy technologies. With a total of 7 patents to his name, Oeth's work has advanced the methods of obtaining genetic information from biological samples.
Latest Patents
Oeth's latest patents include groundbreaking inventions such as "Devices, systems and methods for ultra-low volume liquid biopsy." This invention provides devices, systems, kits, and methods for obtaining genetic information from cell-free fetal nucleic acids in ultra-low amounts of biological samples. The convenience of obtaining ultra-low amounts of samples allows these methods to be employed at a point of need. Another notable patent is "Detection and quantification of biomolecules using mass spectrometry." This invention outlines a method for detecting target nucleic acids using detector oligonucleotides that are detectable by mass spectrometry. The method leverages the 5' to 3' nuclease activity of a nucleic acid polymerase to cleave oligonucleotide probes from hybridized duplexes, facilitating detection through mass spectrometry.
Career Highlights
Throughout his career, Oeth has worked with notable companies such as Sequenom, Inc. and Juno Diagnostics, Inc. His experience in these organizations has allowed him to refine his expertise in the development of innovative diagnostic technologies.
Collaborations
Oeth has collaborated with esteemed colleagues, including Dirk Johannes Van Den Boom and Payam Mahboubi. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Paul Andrew Oeth is a distinguished inventor whose work in liquid biopsy technologies has the potential to revolutionize genetic testing. His innovative patents and collaborations highlight his commitment to advancing the field of biotechnology.